Comparison of phenol block and botulinus toxin type a in the treatment of spastic foot after stroke: A randomized, double-blind trial

American Journal of Physical Medicine and Rehabilitation

Volumn 77, Issue 6, 1998, Pages 510-515

  Kirazli, Yesim ^a   On, Arzu Yagiz ^a   Kismali, Banu ^a   Aksit, Ramazan ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Botulinus Toxin; Phenol Block; Spasticity; Stroke

Indexed keywords

DRUG THERAPY; ELECTROMYOGRAPHY; FUNCTIONAL ASSESSMENT; GAIT ANALYSIS; MUSCLE; NEUROPHYSIOLOGY; PHENOLS;

BOTULINUS TOXIN; PHENOL BLOCK; SPASTICITY;

NEUROMUSCULAR REHABILITATION;

BOTULINUM TOXIN A; PHENOL;

ARTICLE; BRACE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; ELECTROMYOGRAPHY; FUNCTIONAL ASSESSMENT; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MYOCLONUS; NERVE BLOCK; SCORING SYSTEM; SPASTICITY; STROKE; TIBIAL NERVE; TREATMENT OUTCOME;

ADULT; AGED; BOTULINUM TOXIN TYPE A; CEREBROVASCULAR DISORDERS; DOUBLE-BLIND METHOD; FOOT DISEASES; HUMANS; INJECTIONS, INTRAMUSCULAR; MIDDLE AGED; MUSCLE SPASTICITY; NERVE BLOCK; NEUROMUSCULAR AGENTS; PHENOL; RANGE OF MOTION, ARTICULAR; SYMPATHOLYTICS; WALKING;

EID: 0344882590     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002060-199811000-00012     Document Type: Article

References (20)

1. Little JW, Massagli TL: Spasticity and associated abnormalities of muscle tone, in: DeLisa JA (ed): Rehabilitation Medicine: Principles and Practice. Philadelphia, Lippincott Company, 1993, pp 666-676.
2. Khalili AA, Harmel MH, Forster S, Benton JG: Management of spasticity by selective peripheral nerve block with dilute phenol solutions in clinical rehabilitation. Arch Phys Med Rehabil 1964;45:513-519.
3. Awad EA: Phenol block for control of hip flexor and adductor spasticity. Arch Phys Med Rehabil 1972;53:554-557.
4. Garland DE, Lining M, Keenan MA: Percutaneous phenol blocks to motor points of spastic forearm muscles in head-injured adults. Arch Phys Med Rehabil 1984;65:243-245.
5. Keenan MAE, Tomas ES, Stone L, Gersten LM: Percutaneous phenol block of the musculocutaneous nerve to control elbow flexor spasticity. J Hand Surg [Am] 1990;15:340-346.
6. Wainapel SF, Haigney D, Labib K: Spastic hemiplegia in a quadriplegic patient: treatment with phenol nerve block. Arch Phys Med Rehabil 1984;65:786-787.
7. Felsenthal G: Pharmacology of phenol in peripheral nerve blocks: a review. Arch Phys Med Rehabil 1974;55:13-16.
8. Snow BJ, Tsui JKC, Bhatt MH, Varelas M, Hashimato SA, Calne DB: Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol 1990;28:512-515.
9. Stein JB, Pine ZM, Miller JR, Brin MF: Borulinum toxin for the treatment of spasticity in multiple sclerosis. Am J Phys Med Rehabil 1993;72:364-368.
10. Dunne JW, Heye N, Dunne SL: Treatment of chronic limb spasticity with botulinum toxin A. J Neurol Neurosurg Psychiatry 1995;58:232-235.
11. Hesse S, Locke D, Malezic M, et al.: Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry 1994;57:1321-1324.
12. Das TK, Park DM: Effect of treatment with botulinum toxin on spasticity. Postgrad Med J 1989;65:208-210.
13. Dengler R, Neyer U, Wohlfarth K, Bettig U, Janzik HH: Local botulinum toxin in the treatment of spastic drop foot. J Neurol 1992;239:375-378.
14. Simpson DM, Alexander DN, O'Brien CF, et al.: Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 1996;46:1306-1310.
15. Grazko MA, Polo KB, Jabbari B: Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology 1995;45:712-717.
16. Pierson SH, Katz DI, Tarsy D: Botulinum toxin A in the treatment of spasticity: functional implications and patient selection. Arch Phys Med Rehabil 1996;77:717-721.
17. Botte MJ, Abrams RA, Bodine-Fowler SC: Treatment of acquired muscle spasticity using peripheral nerve blocks. Orthopedics 1995;18:151-159.
18. Petrillo CR, Knoploch S: Phenol block of the tibial nerve for spasticity: a long-term follow-up study, Int Disabil Stud 1988;10: 97-100
19. Garland DE, Lucie RS, Waters RL: Current uses of open phenol nerve block for adult required spasticity. Clin Orthop 1982;165:217-222.
20. Barnes MP: Experience of botulinum toxin in the management of spasticity. Eur J Neurol 1997;4[Suppl 2]:33-36